Novavax Touts Encouraging Trial Results For COVID/Flu Combo Vaccine

With the initial results of a phase I/II trial, biotech company Novavax reports that the robust immune response produced by its combination COVID-19/flu vaccine is on par with individual flu and COVID jabs. The trial, which was conducted in Australia...